Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07565987 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The APRIL Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer

Study acronym: APRIL
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years 10 months later Jan 30, 2025 → Dec 18, 2029
See other at-risk trials from All India Institute of Medical Sciences

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 3 of 5 entries
    • Study description shortened, about 416 words
  2. Primary completion pushed from Jan 30, 2025 to Dec 18, 2029v2 Show 6 more changesShow less
    • Start date: Feb 1, 2023 to Dec 19, 2026
    • Trial status changed: Recruiting → Not Yet Recruiting
    • Study completion pushed from Jan 30, 2027 to Dec 18, 2029
    • Study description shortened, about 18 words
    • Site details revised
    • Study title shortened, about 1 word
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to test the feasibility \& loco-regional control rate by combining high precision SBRT with chemotherapy in stage III NSCLC in tumor/lymph nodes if tumors/lymph node size with ≤ 6cms in size.
Trial Details
NCT Number NCT07565987
Lead Sponsor All India Institute of Medical Sciences
Conditions
(from sponsor)		 Non Small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov